FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Ulrich Medical 3D-printed Flux-C Cleared

FDA clears an Ulrich Medical 510(k) for its Flux-C 3D-printed porous titanium cervical interbody device.

latest-news-card-1
Federal Register

FDA Assessing NDA/BLA Information Requests

Federal Register notice: FDA announces an opportunity for public comment on a statement of work to assess communication between FDA and sponsors throu...

latest-news-card-1
Human Drugs

Travere Expecting 3-month NDA Review Extension

Travere Therapeutics says it is expecting FDA to extend its review by three months of an accelerated approval-seeking NDA for sparsentan and its use i...

latest-news-card-1
Human Drugs

Revive Therapeutics Amends Protocol on Covid Therapy

Revive Therapeutics finalizes an amended protocol for the companys Phase 3 clinical trial designed to evaluate the safety and efficacy of investigatio...

latest-news-card-1
Biologics

FDA Accepts BioMarin BLA for Gene Therapy

FDA accepts for review a BioMarin BLA resubmission for gene therapy valoctocogene roxaparvovec for adults with severe hemophilia A.

latest-news-card-1
Federal Register

Agency Seeks Consumer Reps on Advisory Committees

Federal Register notice: FDA seeks consumer organizations that are interested in participating in selecting voting and nonvoting consumer representati...

latest-news-card-1
Federal Register

Dietary Supplement GMPs Info Collection

Federal Register notice: FDA seeks comments on an information collection extension entitled Current Good Manufacturing Practice in Manufacturing, Pack...

latest-news-card-1
Medical Devices

CMS Working with FDA on New Device Coverage Rule

Two Centers for Medicare and Medicaid Services officials describe the principles in a new coverage rule for innovative medical devices the agency is d...

latest-news-card-1
Human Drugs

Exela Pharma Recalls 49 Sodium Bicarbonate Lots

Exela Pharma Sciences (Lenoir, NC) recalls 49 lots of sodium bicarbonate injection due to safety concerns.

latest-news-card-1
Human Drugs

FDA Revamping NDA/BLA Information Requests

FDA seeks public comments on a Statement of Work mandated by the recent drug user fee reauthorization to assess communication between the agency and s...